Dashboard
Manage Tickers

PPBTPURPLE BIOTECH LTD.

Nasdaq purple-biotech.com


$ 0.62 $ -0.02 (-2.83 %)    

Friday, 14-Jun-2024 12:44:19 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 0.601
$ 0.62
$ 0.00 x 0
$ 0.00 x 0
$ 0.62 - $ 0.62
$ 0.30 - $ 1.80
20,116
na
15.17M
$ 1.14
$ 1.41
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
06/11/2024 12:06:21

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
06/10/2024 20:31:12

reported-saturday-purple-biotech-revealed-results-from-a-phase-2-study-at-asco-2024-showing-cm24-improved-overall-survival-and-other-efficacy-endpoints-in-pancreatic-cancer
Reported Saturday, Purple Biotech Revealed...
06/03/2024 08:59:43

26% reduction in risk of death (HR=0.74) and 28% risk reduction in progression or death (HR=0.72) in previously-treated patie...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
05/31/2024 16:31:09

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/23/2024 20:31:02

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/23/2024 16:31:11

hc-wainwright--co-reiterates-buy-on-purple-biotech-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Purp...
05/21/2024 15:36:40

HC Wainwright & Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $10 price target.

purple-biotech-q1-2024-gaap-epads-014-beats-015-estimate-cash-9985m
Purple Biotech Q1 2024 GAAP EPADS $(0.14) ...
05/21/2024 11:42:32

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/10/2024 20:31:10

hc-wainwright--co-reiterates-buy-on-purple-biotech-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Purp...
04/26/2024 18:24:25

HC Wainwright & Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $10 price target.

purple-biotech-says-randomized-phase-2-cm24-pancreatic-cancer-study-selected-as-late-breaking-abstract-poster-presentation-at-asco-2024-annual-meeting
Purple Biotech Says Randomized Phase 2 CM2...
04/25/2024 11:25:46

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/22/2024 20:31:12

purple-biotech-reported-preclinical-proof-of-concept-data-for-its-conditionally-activated-tri-specific-antibody-platform
Purple Biotech Reported Preclinical Proof ...
03/14/2024 11:35:38

chardan-capital-maintains-buy-on-purple-biotech-maintains-11-price-target
Chardan Capital Maintains Buy on Purple Bi...
03/07/2024 18:56:09

Chardan Capital analyst Daniil Gataulin maintains Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $11 price target.

hc-wainwright--co-reiterates-buy-on-purple-biotech-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Purp...
03/05/2024 17:07:53

HC Wainwright & Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $10 price target.

purple-biotech-q4-eps-019-inline
Purple Biotech Q4 EPS $(0.19), Inline
03/05/2024 12:58:32

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.19) per share which met the analyst consensus estimate. This is a...

hc-wainwright--co-reiterates-buy-on-purple-biotech-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Purp...
02/27/2024 17:46:24

HC Wainwright & Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $10 price target.

purple-biotech-says-determined-100mgkg-is-the-recommended-phase-2-dose-for-nt219-in-combination-with-cetuximab-in-the-treatment-of-head-and-neck-cancer-based-on-its-phase-12-dose-escalation-study
Purple Biotech Says Determined 100Mg/Kg Is...
02/01/2024 12:38:16

NT219 is a first-in-class small molecule dual inhibitor of IRS1/2 and STAT3. The Phase 1 dose escalation study is being conclud...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
01/10/2024 21:31:09

purple-biotech-says-it-completed-patient-enrollment-in-phase-2-pancreatic-cancer-trial-primary-endpoint-of-the-study-is-expected-during-1h-2024-and-topline-analysis-is-expected-in-2h-2024
Purple Biotech Says It Completed Patient E...
12/14/2023 11:53:27

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)